Fairfield, Bush & Co. Eli Lilly & CO Transaction History

Fairfield, Bush & Co.

$168 Billion
Q3 2024

A detailed history of Fairfield, Bush & Co. transactions in Eli Lilly & CO stock. As of the latest transaction made, Fairfield, Bush & Co. holds 2,726 shares of LLY stock, worth $2.17 Million. This represents 1.44% of its overall portfolio holdings.

Number of Shares

2,726

Previous 2,301 18.47%

Holding current value

$2.17 Million

Previous $2.08 Billion 15.93%

% of portfolio

1.44%

Previous 1.25%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$772.14 - $960.02 $328,159 - $408,008	425 Added 18.47%	2,726 $2.42 Billion
Q2 2024 Aug 15, 2024	BUY	$724.87 - $909.04 $117,428 - $147,264	162 Added 7.57%	2,301 $2.08 Billion
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $14,212 - $19,014	24 Added 1.13%	2,139 $1.66 Billion
Q4 2023 Feb 13, 2024	BUY	$525.19 - $619.13 $101,886 - $120,111	194 Added 10.1%	2,115 $1.23 Billion
Q3 2023 Nov 15, 2023	SELL	$434.7 - $599.3 $10.7 Million - $14.7 Million	-24,555 Reduced 92.74%	1,921 $1.03 Billion
Q2 2023 Aug 15, 2023	SELL	$350.74 - $468.98 $81,020 - $108,334	-231 Reduced 0.86%	26,476 $12.4 Billion
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $7.79 Million - $9.15 Million	25,080 Added 1541.49%	26,707 $9.17 Billion
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $204,184 - $237,915	635 Added 64.01%	1,627 $595 Million
Q3 2022 Nov 07, 2022	BUY	$296.48 - $337.87 $174,033 - $198,329	587 Added 144.94%	992 $321,000
Q2 2022 Aug 09, 2022	BUY	$278.73 - $327.27 $8,361 - $9,818	30 Added 8.0%	405 $131,000
Q1 2022 May 06, 2022	BUY	$234.69 - $291.66 $88,008 - $109,372	375 New	375 $107,000
Q4 2021 Feb 09, 2022	SELL	$224.85 - $279.04 $674,550 - $837,120	-3,000 Closed	0 $0
Q3 2021 Nov 08, 2021	SELL	$221.6 - $272.71 $4.73 Million - $5.82 Million	-21,325 Reduced 87.67%	3,000 $693,000
Q4 2020 Feb 12, 2021	SELL	$130.46 - $172.63 $3,261 - $4,315	-25 Reduced 0.1%	24,325 $4.11 Million
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $34,105 - $41,045	-250 Reduced 1.02%	24,350 $4 Million
Q3 2019 Nov 13, 2019	SELL	$106.79 - $116.16 $5,339 - $5,808	-50 Reduced 0.2%	24,600 $2.75 Million
Q2 2018 Aug 16, 2018	SELL	$75.7 - $86.88 $37,850 - $43,440	-500 Reduced 1.99%	24,650 $2.1 Million
Q1 2018 May 09, 2018	BUY	$74.21 - $87.6 $37,105 - $43,800	500 Added 2.03%	25,150 $1.95 Million
Q2 2017 Aug 15, 2017	BUY	N/A	24,650	24,650 $2.03 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fairfield, Bush & Co., based on Form 13F filings with the SEC.

News

Stay updated on Fairfield, Bush & Co. with notifications on news.

Account

Fairfield, Bush & Co. Eli Lilly & CO Transaction History